Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1988 Feb;51(2):244–249. doi: 10.1136/jnnp.51.2.244

The effect of age of disease onset on neuropsychological performance in Parkinson's disease.

M Hietanen 1, H Teräväinen 1
PMCID: PMC1031537  PMID: 3346689

Abstract

One hundred and eight noninstitutionalized patients with Parkinson's disease were studied to find out whether the age of disease onset affects patients' cognitive, memory and psychomotor performance. "Early onset" patients (whose disease began before 60 years of age) showed a wide spectrum of impairments in neuropsychological performance compared with age-matched normal subjects. However, only one (2%) of these patients was demented according to DSM III criteria. Dementia was more frequent in patients with equivalent disease duration, but with late onset of disease (over 60 years); 13 of such patients (25%) were demented. The present study supports previous findings which show that dementia increases with advancing age in Parkinson's disease. It also suggests that cognitive changes are also found in patients with early onset of disease.

Full text

PDF
249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BECK A. T., WARD C. H., MENDELSON M., MOCK J., ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561–571. doi: 10.1001/archpsyc.1961.01710120031004. [DOI] [PubMed] [Google Scholar]
  2. Birkmayer W., Riederer P., Youdim B. H. Distinction between benign and malignant type of Parkinson's disease. Clin Neurol Neurosurg. 1979;81(3):158–164. doi: 10.1016/0303-8467(79)90003-9. [DOI] [PubMed] [Google Scholar]
  3. Brown R. G., Marsden C. D. How common is dementia in Parkinson's disease? Lancet. 1984 Dec 1;2(8414):1262–1265. doi: 10.1016/s0140-6736(84)92807-1. [DOI] [PubMed] [Google Scholar]
  4. Cools A. R., van den Bercken J. H., Horstink M. W., van Spaendonck K. P., Berger H. J. Cognitive and motor shifting aptitude disorder in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1984 May;47(5):443–453. doi: 10.1136/jnnp.47.5.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Garron D. C., Klawans H. L., Jr, Narin F. Intellectual functioning of persons with idiopathic Parkinsonism. J Nerv Ment Dis. 1972 Jun;154(6):445–452. doi: 10.1097/00005053-197206000-00007. [DOI] [PubMed] [Google Scholar]
  6. Hietanen M., Teräväinen H. Cognitive performance in early Parkinson's disease. Acta Neurol Scand. 1986 Feb;73(2):151–159. doi: 10.1111/j.1600-0404.1986.tb03257.x. [DOI] [PubMed] [Google Scholar]
  7. Hoehn M. M., Yahr M. D. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17(5):427–442. doi: 10.1212/wnl.17.5.427. [DOI] [PubMed] [Google Scholar]
  8. Jellinger K., Riederer P. Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity. Adv Neurol. 1984;40:199–210. [PubMed] [Google Scholar]
  9. Koller W. C. Disturbance of recent memory function in parkinsonian patients on anticholinergic therapy. Cortex. 1984 Jun;20(2):307–311. doi: 10.1016/s0010-9452(84)80051-9. [DOI] [PubMed] [Google Scholar]
  10. Lees A. J., Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain. 1983 Jun;106(Pt 2):257–270. doi: 10.1093/brain/106.2.257. [DOI] [PubMed] [Google Scholar]
  11. Lesser R. P., Fahn S., Snider S. R., Cote L. J., Isgreen W. P., Barrett R. E. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology. 1979 Sep;29(9 Pt 1):1253–1260. doi: 10.1212/wnl.29.9_part_1.1253. [DOI] [PubMed] [Google Scholar]
  12. Lieberman A., Dziatolowski M., Kupersmith M., Serby M., Goodgold A., Korein J., Goldstein M. Dementia in Parkinson Disease. Ann Neurol. 1979 Oct;6(4):355–359. doi: 10.1002/ana.410060409. [DOI] [PubMed] [Google Scholar]
  13. Marttila R. J., Rinne U. K. Dementia in Parkinson's disease. Acta Neurol Scand. 1976 Nov;54(5):431–441. doi: 10.1111/j.1600-0404.1976.tb04375.x. [DOI] [PubMed] [Google Scholar]
  14. Pederzoli M., Girotti F., Scigliano G., Aiello G., Carella F., Caraceni T. L-dopa long-term treatment in Parkinson's disease: age-related side effects. Neurology. 1983 Nov;33(11):1518–1522. doi: 10.1212/wnl.33.11.1518. [DOI] [PubMed] [Google Scholar]
  15. Perret E. The left frontal lobe of man and the suppression of habitual responses in verbal categorical behaviour. Neuropsychologia. 1974 Jul;12(3):323–330. doi: 10.1016/0028-3932(74)90047-5. [DOI] [PubMed] [Google Scholar]
  16. Quinn N. P., Rossor M. N., Marsden C. D. Dementia and Parkinson's disease--pathological and neurochemical considerations. Br Med Bull. 1986 Jan;42(1):86–90. doi: 10.1093/oxfordjournals.bmb.a072104. [DOI] [PubMed] [Google Scholar]
  17. Sadeh M., Braham J., Modan M. Effects of anticholinergic drugs on memory in Parkinson's disease. Arch Neurol. 1982 Oct;39(10):666–667. doi: 10.1001/archneur.1982.00510220064017. [DOI] [PubMed] [Google Scholar]
  18. Syndulko K., Gilden E. R., Hansch E. C., Potvin A. R., Tourtellotte W. W., Potvin J. H. Decreased verbal memory associated with anticholinergic treatment in Parkinson's disease patients. Int J Neurosci. 1981;14(1-2):61–66. doi: 10.3109/00207458108985816. [DOI] [PubMed] [Google Scholar]
  19. Weingartner H., Burns S., Diebel R., LeWitt P. A. Cognitive impairments in Parkinson's disease: distinguishing between effort-demanding and automatic cognitive processes. Psychiatry Res. 1984 Mar;11(3):223–235. doi: 10.1016/0165-1781(84)90071-4. [DOI] [PubMed] [Google Scholar]
  20. Zetusky W. J., Jankovic J., Pirozzolo F. J. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology. 1985 Apr;35(4):522–526. doi: 10.1212/wnl.35.4.522. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES